Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Videos

Advances in Diagnostic and Treatment Research in Sports Concussion
Videos
Advances in Diagnostic and Treatment Research in Sports Concussion
11/02/2020
In this video, Christina L. Master, MD, details the increasing interest in characterizing concussion subtypes to help target interventions, the ongoing search for the “holy grail” diagnostic test for concussion, and more. She recently...
In this video, Christina L. Master, MD, details the increasing interest in characterizing concussion subtypes to help target interventions, the ongoing search for the “holy grail” diagnostic test for concussion, and more. She recently...
In this video, Christina L....
11/02/2020
Neurology

Advertisement

Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: Key Clinical Takeaways
Videos
Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: Key Clinical Takeaways
11/01/2020
In this video, Laura T. Safar, MD, addresses the impact of neuropsychiatric disorders on quality of life among patients with multiple sclerosis, and the importance of monitoring the prevalence of depression, anxiety, and cognitive disorders...
In this video, Laura T. Safar, MD, addresses the impact of neuropsychiatric disorders on quality of life among patients with multiple sclerosis, and the importance of monitoring the prevalence of depression, anxiety, and cognitive disorders...
In this video, Laura T. Safar,...
11/01/2020
Neurology
MS and COVID-19: The Pros and Cons of Telemedicine
Videos
MS and COVID-19: The Pros and Cons of Telemedicine
10/27/2020
In this video, Florian Thomas, MD, discusses the use of telemedicine among patients with multiple sclerosis during the ongoing pandemic, and what can and cannot be accomplished in a telemedicine visit.
In this video, Florian Thomas, MD, discusses the use of telemedicine among patients with multiple sclerosis during the ongoing pandemic, and what can and cannot be accomplished in a telemedicine visit.
In this video, Florian Thomas,...
10/27/2020
Neurology
Managing Migraine During COVID-19: Treatment Challenges
Videos
Managing Migraine During COVID-19: Treatment Challenges
10/23/2020
In this video, Regina Krel, MD, discusses challenges that arose during the pandemic when it came to administering migraine treatments to her patients, especially during the shelter-in-place order in New Jersey, and how she overcame these...
In this video, Regina Krel, MD, discusses challenges that arose during the pandemic when it came to administering migraine treatments to her patients, especially during the shelter-in-place order in New Jersey, and how she overcame these...
In this video, Regina Krel, MD,...
10/23/2020
Neurology

Advertisement

Bridging Knowledge Gaps in Sports Concussion Prevention and Treatment: Evidence for Rule Changes and More
Videos
Bridging Knowledge Gaps in Sports Concussion Prevention and Treatment: Evidence for Rule Changes and More
10/23/2020
In this video, Christina L. Master, MD, reviews evidence of the role of rule changes in preventing concussion in hockey and football, research on active rehabilitation in the treatment of concussion, and more. She recently discussed these...
In this video, Christina L. Master, MD, reviews evidence of the role of rule changes in preventing concussion in hockey and football, research on active rehabilitation in the treatment of concussion, and more. She recently discussed these...
In this video, Christina L....
10/23/2020
Neurology
Managing Migraine During COVID-19: Impact on Patients
Videos
Managing Migraine During COVID-19: Impact on Patients
10/21/2020
In this video, Regina Krel, MD, discusses the emotional impact of the ongoing pandemic on her patients with migraine.
In this video, Regina Krel, MD, discusses the emotional impact of the ongoing pandemic on her patients with migraine.
In this video, Regina Krel, MD,...
10/21/2020
Neurology
Videos
Erenumab: A Game-Changer for Chronic Migraine With or Without Acute Medication Overuse
10/20/2020
In this video, Stewart Tepper, MD, discusses the findings from his recent trial on the long-term efficacy of erenumab among patients with chronic migraine with or without acute medication overuse, and how erenumab has changed the way he...
In this video, Stewart Tepper, MD, discusses the findings from his recent trial on the long-term efficacy of erenumab among patients with chronic migraine with or without acute medication overuse, and how erenumab has changed the way he...
In this video, Stewart Tepper,...
10/20/2020
Neurology

Advertisement

MS and COVID-19: The Use of Disease-Modifying Therapies
Videos
MS and COVID-19: The Use of Disease-Modifying Therapies
10/19/2020
In this video, Florian Thomas, MD, discusses the use of disease-modifying therapies among patients with multiple sclerosis during the ongoing pandemic.
In this video, Florian Thomas, MD, discusses the use of disease-modifying therapies among patients with multiple sclerosis during the ongoing pandemic.
In this video, Florian Thomas,...
10/19/2020
Neurology
Michelle Monje, MD, PhD, Discusses the Neuronal Regulation of the Pathobiology of Brain Tumors
Videos
Michelle Monje, MD, PhD, Discusses the Neuronal Regulation of the Pathobiology of Brain Tumors
10/12/2020
In this video, Dr Monje discusses recent evidence regarding the neuronal regulation of the pathobiology of brain tumors and potential implications of this evidence. Dr Monje was presented with an award for this talk at the American...
In this video, Dr Monje discusses recent evidence regarding the neuronal regulation of the pathobiology of brain tumors and potential implications of this evidence. Dr Monje was presented with an award for this talk at the American...
In this video, Dr Monje...
10/12/2020
Neurology
Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: Interdisciplinary Treatment Is Key
Videos
Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: Interdisciplinary Treatment Is Key
10/06/2020
In this video, Laura T. Safar, MD, details the importance of regular, interdisciplinary collaboration between neurologists, psychiatrists, and other clinicians in the treatment of patients with multiple sclerosis and comorbid neuropsychiatric...
In this video, Laura T. Safar, MD, details the importance of regular, interdisciplinary collaboration between neurologists, psychiatrists, and other clinicians in the treatment of patients with multiple sclerosis and comorbid neuropsychiatric...
In this video, Laura T. Safar,...
10/06/2020
Neurology

Advertisement

Advertisement

Advertisement

News

Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
News
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
11/01/2024
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug...
11/01/2024
Neurology
Gene therapy
News
Concerns Linger After Gene Therapy Shows Long-Term Benefit for Cerebral Adrenoleukodystrophy
10/28/2024
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel...
10/28/2024
Neurology
Patient with family
News
During Recovery, Stroke Patients Benefit from Supportive Social Networks
10/24/2024
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and...
10/24/2024
Neurology
International Stroke Burden Saw Hike Over Last 30 Years
News
International Stroke Burden Saw Hike Over Last 30 Years
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has...
10/22/2024
Neurology
Hands holding a head in profile with an illustrated heart over brain
News
Antiseizure Meds May Increase Cardiovascular Risk in Older Adults With Epilepsy
10/21/2024
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy...
10/21/2024
Neurology
FDA approval stamp
News
FDA Approves Infusion Treatment for Advanced Parkinson Disease in Adults
10/18/2024
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa...
10/18/2024
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
News
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
10/15/2024
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to...
10/15/2024
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use